"Mice, Nude" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.
| Descriptor ID |
D008819
|
| MeSH Number(s) |
B01.050.150.900.649.313.992.635.505.500.550.500
|
| Concept/Terms |
Mice, Nude- Mice, Nude
- Athymic Mice
- Mouse, Nude
- Nude Mouse
- Nude Mice
- Mouse, Athymic
- Athymic Mouse
- Mice, Athymic
|
Below are MeSH descriptors whose meaning is more general than "Mice, Nude".
Below are MeSH descriptors whose meaning is more specific than "Mice, Nude".
This graph shows the total number of publications written about "Mice, Nude" by people in this website by year, and whether "Mice, Nude" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 19 | 19 |
| 1995 | 0 | 36 | 36 |
| 1996 | 0 | 32 | 32 |
| 1997 | 0 | 35 | 35 |
| 1998 | 0 | 44 | 44 |
| 1999 | 0 | 47 | 47 |
| 2000 | 0 | 53 | 53 |
| 2001 | 0 | 45 | 45 |
| 2002 | 0 | 79 | 79 |
| 2003 | 0 | 53 | 53 |
| 2004 | 1 | 63 | 64 |
| 2005 | 0 | 83 | 83 |
| 2006 | 1 | 92 | 93 |
| 2007 | 0 | 97 | 97 |
| 2008 | 0 | 103 | 103 |
| 2009 | 1 | 94 | 95 |
| 2010 | 2 | 110 | 112 |
| 2011 | 0 | 142 | 142 |
| 2012 | 0 | 110 | 110 |
| 2013 | 0 | 99 | 99 |
| 2014 | 0 | 123 | 123 |
| 2015 | 1 | 106 | 107 |
| 2016 | 0 | 95 | 95 |
| 2017 | 0 | 78 | 78 |
| 2018 | 0 | 79 | 79 |
| 2019 | 0 | 68 | 68 |
| 2020 | 0 | 60 | 60 |
| 2021 | 0 | 55 | 55 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 3 | 3 |
| 2024 | 2 | 4 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice, Nude" by people in Profiles.
-
Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts. Cell Commun Signal. 2024 Nov 14; 22(1):545.
-
WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma. Cancer Res. 2024 Sep 04; 84(17):2776-2791.
-
From mitochondria to tumor suppression: ACAT1's crucial role in gastric cancer. Front Immunol. 2024; 15:1449525.
-
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma. Adv Sci (Weinh). 2024 Aug; 11(30):e2307747.
-
Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus. J Cell Physiol. 2024 Aug; 239(8):e31302.
-
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy. Gastroenterology. 2024 Jul; 167(2):281-297.
-
Sodium Butyrate Inhibits the Malignant Proliferation of Colon Cancer Cells via the miR-183/DNAJB4 Axis. Biochem Genet. 2024 Oct; 62(5):4174-4190.
-
Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Res Commun. 2023 06; 3(6):1078-1092.
-
Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2023 04 03; 29(7):1344-1359.
-
Alendronate conjugate for targeted delivery to bone-forming prostate cancer. Talanta. 2023 May 01; 256:124308.